Loading...
The Changing Landscape of Treatment Options For Metastatic Castrate-Resistant Prostate Cancer: Challenges and Solutions for Physicians and Patients
Four recently approved drugs (cabazitaxel, sipuleucel-T, abiraterone, and denosumab), along with emerging therapies, bone-building therapies, hormonal treatments, and immunotherapies, have all demonstrated promise in advanced prostate cancer. It appears that the best outcomes will be achieved from t...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MediMedia USA, Inc.
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3474424/ https://ncbi.nlm.nih.gov/pubmed/23091338 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|